Author: Staff

Frank H. Valone III, MD, is an orthopedic spine surgeon at California Pacific Orthopaedics in San Francisco.

Johnson & Johnson reported orthopedics sales decreased 1 percent in the fourth quarter of 2018 to $2.2 billion; for the full year, orthopedic sales dipped 1.9 percent to $8.8 billion.

European private equity firm Nordic Capital acquired majority holding in Orchid Orthopedic Solutions from Altor Fund III.

Johnson & Johnson reported fourth quarter and full-year results for DePuy Synthes, its orthopedics division.

A new report from the Blue Cross Blue Shield Association shows spending for planned orthopedic surgeries have grown significantly over the past decade.

Joshua Carothers, MD, is tapping into New Mexico's growing film industry with VIP StarNetwork, a healthcare service for film sets in the state, according to the Albuquerque Journal.

The American Association of Hip and Knee Surgeons advises clinicians to avoid prescribing opioids to treat hip and knee osteoarthritis, using them only for exceptional circumstances.

The American Association of Hip and Knee Surgeons does not currently recommend biologic treatments for advanced hip or knee arthritis, according to a new position statement.

Here are the top 10 most-read articles on Becker's Spine Review from Jan. 14-18.

Daniel T. Laich, DO, is a board-certified neurosurgeon and neurosurgery chief at Chicago-based Swedish Covenant Health.